Pharmacokinetic modeling and simulation of etodolac following single oral administration in dogs.
This study will help to enact a more accurate optimal dosing regimen of etodolac in dogs with osteoarthritis, and may be useful in developing novel formulation of etodolac for human in the future.
PMID: 30216103 [PubMed - as supplied by publisher] (Source: Xenobiotica)
Source: Xenobiotica - September 14, 2018 Category: Research Authors: Baek IH Tags: Xenobiotica Source Type: research
A new design for a chronological release profile of etodolac from coated bilayer tablets: in-vitro and in-vivo assessment
Publication date: Available online 31 August 2018Source: Journal of Advanced ResearchAuthor(s): Kirolos R Georgy, Ragwa M Farid, Randa Latif, Ehab R BendasAbstractRepeated dose medication usually maximizes adverse effects, while sustained release systems did not offer a fast onset of action. Etodolac was formulated to enable pulsatile and sustained drug release, which was chronologically more suitable as an anti-inflammatory drug. Eudragit® RSPO, Eudragit® RLPO and HPMC K15M were added in the sustained release layer and tried in different ratios. Croscarmellose sodium or sodium starch glycolate were used as superdisinteg...
Source: Journal of Advanced Research - September 1, 2018 Category: Research Source Type: research
Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome
Publication date: Available online 22 May 2018Source: Brain, Behavior, and ImmunityAuthor(s): Rita Haldar, Lee Shaashua, Hagar Lavon, Yasmin A. Lyons, Oded Zmora, Eran Sharon, Yehudit Birnbaum, Tanir Allweis, Anil K. Sood, Iris Barshack, Steve Cole, Shamgar Ben-EliyahuAbstractCatecholamines and prostaglandins are secreted abundantly during the perioperative period in response to stress and surgery, and were shown by translational studies to promote tumor metastasis. Here, in a phase-II biomarker clinical trial in breast cancer patients (n = 38), we tested the combined perioperative use of the β-blocker, propranolol, a...
Source: Brain, Behavior, and Immunity - July 10, 2018 Category: Neurology Source Type: research
Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome
Publication date: Available online 22 May 2018 Source:Brain, Behavior, and Immunity Author(s): Rita Haldar, Lee Shaashua, Hagar Lavon, Yasmin A. Lyons, Oded Zmora, Eran Sharon, Yehudit Birnbaum, Tanir Allweis, Anil K. Sood, Iris Barshack, Steve Cole, Shamgar Ben-Eliyahu Catecholamines and prostaglandins are secreted abundantly during the perioperative period in response to stress and surgery, and were shown by translational studies to promote tumor metastasis. Here, in a phase-II biomarker clinical trial in breast cancer patients (n = 38), we tested the combined perioperative use of the β-blocker, propra...
Source: Brain, Behavior, and Immunity - May 29, 2018 Category: Neurology Source Type: research
Perioperative inhibition of β-adrenergic andCOX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Abstract
Catecholamines and prostaglandins are secreted abundantly during the perioperative period in response to stress and surgery, and were shown by translational studies to promote tumor metastasis. Here, in a phase-II biomarker clinical trial in breast cancer patients (n=38), we tested the combined perioperative use of the β-blocker, propranolol, and the COX2-inhibitor, etodolac, scheduled for 11 consecutive perioperative days, starting 5 days before surgery. Blood samples were taken before treatment (T1), on the mornings before and after surgery (T2&T3), and after treatment cessation (T4). Drugs...
Source: Brain, Behavior, and Immunity - May 22, 2018 Category: Neurology Authors: Haldar R, Shaashua L, Lavon H, Lyons YA, Zmora O, Sharon E, Birnbaum Y, Allweis T, Sood AK, Barshack I, Cole S, Ben-Eliyahu S Tags: Brain Behav Immun Source Type: research
Perioperative inhibition of β-adrenergic andCOX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome
Publication date: Available online 22 May 2018 Source:Brain, Behavior, and Immunity Author(s): Rita Haldar, Lee Shaashua, Hagar Lavon, Yasmin A. Lyons, Oded Zmora, Eran Sharon, Yehudit Birnbaum, Tanir Allweis, Anil K. Sood, Iris Barshack, Steve Cole, Shamgar Ben-Eliyahu Catecholamines and prostaglandins are secreted abundantly during the perioperative period in response to stress and surgery, and were shown by translational studies to promote tumor metastasis. Here, in a phase-II biomarker clinical trial in breast cancer patients (n=38), we tested the combined perioperative use of the β-blocker, propranolol,...
Source: Brain, Behavior, and Immunity - May 22, 2018 Category: Neurology Source Type: research
Mechanistic insights of the controlled release properties of amide adhesive and hydroxyl adhesive.
In conclusion, AACONH2 had stronger controlled release properties compared with AAOH, which was mainly caused by the stronger interactions between amide groups and drugs. The amide PSA synthesized in the present study was a potential sustained-release excipient for transdermal drug delivery system.
PMID: 29625213 [PubMed - as supplied by publisher] (Source: European Journal of Pharmaceutical Sciences)
Source: European Journal of Pharmaceutical Sciences - April 3, 2018 Category: Drugs & Pharmacology Authors: Luo Z, Wan X, Liu C, Fang L Tags: Eur J Pharm Sci Source Type: research
Synthesis, anticancer activity, and molecular modeling of etodolac ‐thioether derivatives as potent methionine aminopeptidase (type II) inhibitors
Archiv der Pharmazie, EarlyView. (Source: Archiv der Pharmazie)
Source: Archiv der Pharmazie - March 25, 2018 Category: Drugs & Pharmacology Source Type: research
Etodolac: & #946;-cyclodextrin inclusion complex as a novel fluorescent chemosensor probe for Ba2+
(Source: Journal of Carbohydrate Chemistry)
Source: Journal of Carbohydrate Chemistry - March 2, 2018 Category: Chemistry Authors: Sivakumar, K. Parameswari, M. Stalin, T. Source Type: research
Comparison of clinical effectiveness and safety of newer nonsteroidal anti-inflammatory drugs in patients of osteoarthritis of knee joint: A randomized, prospective, open-label parallel-group study
CONCLUSION: It was concluded that lornoxicam was more effective and better tolerated NSAID than etodolac and diclofenac in treatment of knee joint OA. (Source: Indian Journal of Pharmacology)
Source: Indian Journal of Pharmacology - February 8, 2018 Category: Drugs & Pharmacology Authors: Yashika Garg Jatinder Singh HS Sohal Rajeshwari Gore Arun Kumar Source Type: research
Expression of tissue inhibitor of metalloproteinases and matrix metalloproteinases in the ischemic brain of photothrombosis model mice
Middle cerebral artery occlusion (MCAO) is the most widely used animal model of ischemic stroke. This model well recapitulates the pathological features of most human cases; however, MCAO is technically difficult to achieve in mice and has some disadvantages for investigating the molecular mechanisms of pathological progression in stroke. The recently developed photothrombosis model may be more suitable for research on the molecular mechanisms of ischemic stroke in mice. Yet, similarities and differences between the photothrombosis and MCAO models are not well characterized. In the present study, we examined the expression...
Source: NeuroReport - February 2, 2018 Category: Neurology Tags: Clinical Neuroscience Source Type: research
Preemptive use of etodolac on tooth sensitivity after in-office bleaching: a randomized clinical trial
Conclusion: A single-dose preemptive administration of 400 mg of etodolac did not affect either risk of tooth sensitivity or level of sensitivity reported by patients, during or after the in-office tooth bleaching procedure. (Source: Journal of Applied Oral Science)
Source: Journal of Applied Oral Science - February 1, 2018 Category: Dentistry Source Type: research
Association of Physicians of India: Position Statement on Role of Chirally Pure Molecules in Clinical Practice.
Authors: Nadkar MY, Tiwaskar M, Kalra S, Shah SN, Bansode BR, Dutta A, Bajaj S, Aggarwal S, Balhara YPS, Das AK, Dhamija P, Gupta YK, Jacob J, Mishra S, Narasingan SN, Ponde CK, Prabhoo R, S B, Sahay M, Sahay RK, Sathyamurthy I, Tiwaskar S, Vora A
Abstract
Chirally pure molecules or enantiomers are non-superimposable mirror images of each other with a chiral center (such as carbon, sulphur, nitrogen or phosphorous atom). An equimolar mixture of enantiomers forms a racemate. Chirally pure molecules (single enantiomers) are important in the field of drug discovery as the drug targets such as enzymes and rece...
Source: Journal of the Association of Physicians of India - January 14, 2018 Category: General Medicine Tags: J Assoc Physicians India Source Type: research
Association Between Concomitant Use of Acyclovir or Valacyclovir with NSAIDs and an Increased Risk of Acute Kidney Injury:Data Mining of FDA Adverse Event Reporting System.
The objective of the study was to investigate reports of acute kidney injury(AKI) events associated with the concomitant use of oral acyclovir or valacyclovir with an NSAID by using the United States Food and Drug Administration(FDA) Adverse Event Reporting System (AERS) database between January 2004 and June 2012. The frequency of AKI events in patients while simultaneously taking either acyclovir or valacyclovir and an NSAID was compared using the Chi-square test. The effect of concomitant use of acyclovir or valacyclovir and individual NSAIDs on AKI was analyzed by the reporting odds ratio (ROR).The results showed that...
Source: Biological and Pharmaceutical Bulletin - November 28, 2017 Category: Drugs & Pharmacology Authors: Yue Z, Shi J, Li H, Li H Tags: Biol Pharm Bull Source Type: research
